v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 186,984  
Operating expenses:    
Costs of services 170,101  
Research, development and patents 1,262,514 $ 1,839,802
General and administrative 1,590,175 1,362,708
Total operating expenses 3,022,790 3,202,510
Operating loss (2,835,806) (3,202,510)
Interest income 252,964 336,111
Other income (expense), net (3,416) 2,279
Net loss $ (2,586,258) $ (2,864,120)
Basic net loss per common share $ (0.05) $ (0.06)
Diluted net loss per common share $ (0.05) $ (0.06)
Shares used to compute basic net loss per common share 49,221,246 49,046,246
Shares used to compute diluted net loss per common share 49,221,246 49,046,246
Net loss $ (2,586,258) $ (2,864,120)
Other comprehensive loss, net of tax:    
Foreign currency translation adjustments (950) 5,102
Comprehensive loss $ (2,587,208) $ (2,859,018)